Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q4 FY22 results · Jan–Mar 2022
Unichem Laboratories reported revenue from operations of ₹369.95 crore (up 35.0% from Q4 FY21) and net profit of ₹71.47 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 369.95 | 274.12 | +35.0% | 311.31 | +18.8% |
| Other income | 14.39 | 7.83 | +83.8% | 14.66 | −1.8% |
| Total income | 384.34 | 281.95 | +36.3% | 325.96 | +17.9% |
| Profit before tax | 57.94 | 3.20 | 18x | (10.64) | Turned profit |
| Net profit for the period | 71.47 | (0.41) | Turned profit | (14.10) | Turned profit |
| EPS, basic (₹) | 10.15 | (0.06) | Turned profit | (2.01) | Turned profit |
| Net margin (%) | 19.3 | -0.1 | -4.5 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 276.86 | 261.09 | +6.0% | 248.29 | +11.5% |
| Other income | 9.08 | 4.91 | +85.1% | 15.09 | −39.8% |
| Total income | 285.94 | 265.99 | +7.5% | 263.38 | +8.6% |
| Profit before tax | (0.28) | 12.43 | Turned loss | (23.50) | Loss narrowed |
| Net profit for the period | 17.33 | 0.86 | 20x | (23.50) | Turned profit |
| EPS, basic (₹) | 2.46 | 0.12 | 20x | (3.34) | Turned profit |
| Net margin (%) | 6.3 | 0.3 | -9.5 |
Consolidated
- Filed with BSE
- 27 May 2022, 18:24 IST
- Board meeting
- 27 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2022, 18:24 IST
- Board meeting
- 27 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE